nimustine has been researched along with Disease Exacerbation in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (77.78) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoshimaru, M; Kawanabe, Y; Kihara, S; Koizumi, T; Sasaki, N; Sawada, M; Ueda, S; Yukawa, H | 1 |
| Fujii, T; Saito, N; Takahashi, K; Tanaka, M; Todo, T; Tsuno, NH | 1 |
| Hosoi, H; Iehara, T; Misawa, A; Sawada, T; Sugimoto, T; Tsuchiya, K | 1 |
| Bamberg, M; Koch, R; Krauseneck, P; Müller, B; Weller, M | 1 |
| Bratengeier, K; Flentje, M; Kölbl, O; Ruprecht, K; Vince, GH; Vordermark, D | 1 |
| Flentje, M; Kölbl, O; Rieckmann, P; Roggendorf, W; Ruprecht, K; Vince, GH; Vordermark, D; Warmuth-Metz, M | 1 |
| Chang, CC; Gondo, G; Hayashi, A; Ito, S; Kanno, H; Kyuma, Y; Nishimura, S; Ono, A; Sasaki, T; Sato, H; Shimizu, N; Tanaka, M; Yamamoto, I | 1 |
| Deininger, MH; Grote, E; Meyermann, R; Wickboldt, J | 1 |
| Goto, T; Iwasaki, T; Kimura, T; Kino, T; Kitamura, I; Kochii, M; Kuratsu, J; Nishi, T; Saito, Y; Shiraishi, S; Tada, K; Takeshima, H; Uemura, S; Ushio, Y; Yamamoto, K | 1 |
3 trial(s) available for nimustine and Disease Exacerbation
| Article | Year |
|---|---|
Human umbilical vein endothelial cell vaccine therapy in patients with recurrent glioblastoma.
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Cancer Vaccines; Chemotherapy, Adjuvant; Dacarbazine; Disease Progression; Disease-Free Survival; Female; Glioblastoma; Human Umbilical Vein Endothelial Cells; Humans; Immunotherapy, Active; Male; Middle Aged; Nimustine; Temozolomide | 2013 |
Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Disease Progression; Female; Glioblastoma; Glioma; Humans; Male; Middle Aged; Nimustine; Prognosis; Prospective Studies; Survival Analysis; Teniposide; Treatment Outcome | 2003 |
Randomized comparison of intra-arterial versus intravenous infusion of ACNU for newly diagnosed patients with glioblastoma.
Topics: Adolescent; Adult; Aged; Aging; Antineoplastic Agents; Brain Neoplasms; Disease Progression; Female; Glioblastoma; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Middle Aged; Nimustine; Proportional Hazards Models; Prospective Studies; Survival Analysis | 2000 |
6 other study(ies) available for nimustine and Disease Exacerbation
| Article | Year |
|---|---|
Radiation-induced spinal cord anaplastic astrocytoma subsequent to radiotherapy for testicular seminoma.
Topics: Antineoplastic Agents; Astrocytoma; Chemotherapy, Adjuvant; Combined Modality Therapy; Dacarbazine; Disease Progression; Fatal Outcome; Humans; Hydrocephalus; Laminectomy; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Nimustine; Seminoma; Spinal Cord Compression; Spinal Cord Neoplasms; Syringomyelia; Temozolomide; Testicular Neoplasms; Thoracic Vertebrae; Time Factors | 2012 |
Regression of refractory rhabdomyosarcoma after allogeneic stem-cell transplantation.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease Progression; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fatal Outcome; Female; Graft vs Tumor Effect; Head and Neck Neoplasms; Humans; Ifosfamide; Immunosuppressive Agents; Neoplasm Recurrence, Local; Nimustine; Peripheral Blood Stem Cell Transplantation; Rhabdomyosarcoma; Transplantation Conditioning; Vincristine | 2003 |
Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma.
Topics: Antineoplastic Agents; Brain Neoplasms; Disease Progression; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Glioblastoma; Glioma; Humans; Neoplasm Recurrence, Local; Nimustine; Prognosis; Radiosurgery; Radiotherapy; Recurrence; Stereotaxic Techniques; Teniposide; Time Factors; Treatment Outcome | 2005 |
Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Craniotomy; Disease Progression; Disease-Free Survival; Female; Glioblastoma; Humans; Life Tables; Male; Middle Aged; Nimustine; Oligodendroglia; Oligodendroglioma; Prognosis; Radiotherapy, Adjuvant; Survival Analysis; Teniposide; Treatment Outcome | 2006 |
Collagen gel matrix assay as an in vitro chemosensitivity test for malignant astrocytic tumors.
Topics: Adult; Aged; Antineoplastic Agents; Astrocytoma; Carboplatin; Central Nervous System Neoplasms; Cisplatin; Collagen; Disease Progression; Disease-Free Survival; Drug Screening Assays, Antitumor; Etoposide; Female; Fibrin Foam; Follow-Up Studies; Glioblastoma; Humans; Japan; Karnofsky Performance Status; Male; Middle Aged; Nimustine; Sensitivity and Specificity; Survival Analysis; Tissue Adhesives; Treatment Outcome; Tumor Burden; Tumor Cells, Cultured | 2007 |
Distinct radiochemotherapy protocols differentially influence cellular proliferation and expression of p53 and Bcl-2 in glioblastoma multiforme relapses in vivo.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers; Brain Neoplasms; Cell Division; Chemotherapy, Adjuvant; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Genes; Genes, bcl-2; Glioblastoma; GTP-Binding Proteins; Humans; Ki-67 Antigen; Life Tables; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Nimustine; Protein Glutamine gamma Glutamyltransferase 2; Proto-Oncogene Proteins c-bcl-2; Radiotherapy, Adjuvant; Survival Analysis; Teniposide; Transglutaminases; Tumor Suppressor Protein p53 | 2000 |